Clinical Trials Logo

Filter by:
NCT ID: NCT00876447 Completed - Overactive Bladder Clinical Trials

A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis

Start date: January 1, 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the long-term safety and effectiveness of botulinum toxin type A on patients with overactive bladder as a result of spinal cord injury or multiple sclerosis. This is a follow-up study to two Allergan sponsored studies (NCT00311376 and NCT00461292).

NCT ID: NCT00875810 Completed - Clinical trials for Degenerative Cervical Disc Disease

PRESTIGE Observational Study

Start date: April 2008
Phase: N/A
Study type: Observational

Prestige artificial disc replacement is an alternative treatment option with 16 years of experience addressing the unmet needs of surgical fusion interventions. Previous studies on the PRESTIGE® cervical disc have proven the safety and effectiveness of artificial disc surgery with level I evidence. The PRESTIGE Observational Study is intended to collect prospectively observational data primarily on the Quality of Life (QoL).

NCT ID: NCT00873210 Completed - Renal Cancer Clinical Trials

Study In Patients With Kidney Cancer Treated With Sutent

Start date: May 2009
Phase: N/A
Study type: Observational

Objective of this study is to increase knowledge about safety, tolerability, quality of life and efficacy under conditions of routine use of sunitinib.

NCT ID: NCT00872066 Completed - Clinical trials for Rheumatoid Arthritis

A Study to Assess the Long-term Performance of SmartSet® HV and SmartSet® GHV Bone Cements in Primary Total Hip Replacement

Start date: March 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to monitor the performance of artificial hip joints implanted with two different bone cements, SmartSet® HV and SmartSet® GHV, in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to SmartSet® HV or SmartSet® GHV and will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments

NCT ID: NCT00870051 Completed - Clinical trials for Aortic Aneurysm, Abdominal

Endurant Stent Graft Natural Selection Global Postmarket Registry

ENGAGE
Start date: April 8, 2009
Phase:
Study type: Observational

The purpose of ENGAGE is to prospectively collect global 'real world' data on the Endurant Stent Graft System from AAA subjects.

NCT ID: NCT00869986 Completed - Clinical trials for Relapsing Remitting Multiple Sclerosis

A Study for Patients With Relapsing Remitting Multiple Sclerosis

MINDSET01
Start date: November 2006
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to test if dirucotide is safe and effective in treating patients with relapsing remitting multiple sclerosis.

NCT ID: NCT00868959 Completed - Bipolar Depression Clinical Trials

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Start date: April 2009
Phase: Phase 3
Study type: Interventional

This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe for the treatment of patients with bipolar I depression

NCT ID: NCT00865969 Completed - Clinical trials for Peripheral T-cell Lymphoma

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

PTCL
Start date: December 15, 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess efficacy and safety of belinostat in participants with relapsed or refractory peripheral T-cell lymphoma (PTCL), who failed at least one prior systemic therapy.

NCT ID: NCT00865020 Completed - Hypertension Clinical Trials

Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal

ASSERTIVE
Start date: March 2009
Phase: Phase 4
Study type: Interventional

This study was specifically designed to provide additional information on the mechanism of action of direct renin inhibition postulating the higher-level RAS cascade inhibition. The purpose of this study was to compare the prolonged efficacy and safety of aliskiren to that of telmisartan in mild to moderate hypertensive patients in the 24 hrs Ambulatory Blood Pressure Monitoring setting after a one week treatment withdrawal.

NCT ID: NCT00860288 Completed - Clinical trials for Diabetes Mellitus, Type 2

Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes

Start date: February 2009
Phase: Phase 2/Phase 3
Study type: Interventional

This is a 2-3 period parallel group study with an adaptive element in Type 2 diabetes patients receiving vildagliptin as add-on therapy to metformin